Ainos (NASDAQ:AIMD) Director Sells $51,832.66 in Stock

Ainos, Inc. (NASDAQ:AIMD) Director Chun-Jung Tsai sold 27,718 shares of the business’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $1.87, for a total value of $51,832.66. Following the sale, the director owned 658,199 shares of the company’s stock, valued at approximately $1,230,832.13. The trade was a 4.04% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Chun-Jung Tsai also recently made the following trade(s):

• On Friday, May 22nd, Chun-Jung Tsai sold 1,082 shares of Ainos stock. The stock was sold at an average price of $1.55, for a total value of $1,677.10.

Ainos Trading Down 13.1%

AIMD stock opened at $2.38 on Friday. The company has a market cap of $20.29 million, a P/E ratio of -0.82 and a beta of 2.29. Ainos, Inc. has a twelve month low of $1.26 and a twelve month high of $4.50. The company has a quick ratio of 0.50, a current ratio of 0.55 and a debt-to-equity ratio of 1.58. The business has a fifty day moving average of $1.71 and a 200-day moving average of $1.83.

Ainos (NASDAQ:AIMD) last released its earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share for the quarter. Ainos had a negative return on equity of 160.55% and a negative net margin of 11,912.10%.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded Ainos from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Ainos has an average rating of “Sell”.

Institutional Investors Weigh In On Ainos

Several large investors have recently modified their holdings of the business. Mariner LLC bought a new stake in shares of Ainos in the fourth quarter worth about $37,000. DRW Securities LLC increased its holdings in shares of Ainos by 272.6% in the fourth quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock worth $109,000 after acquiring an additional 48,439 shares in the last quarter. Renaissance Technologies LLC increased its holdings in shares of Ainos by 13.1% in the fourth quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock worth $109,000 after acquiring an additional 7,700 shares in the last quarter. Finally, Two Sigma Investments LP bought a new stake in shares of Ainos in the third quarter worth about $80,000.

Ainos Company Profile

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.